Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual Event

Jun 14, 2020 9:00 AM - Jun 18, 2020 5:00 PM

(Eastern Standard Time)

Fort Washington, PA 19034

DIA 2020 Global Annual Meeting

Approaches for Cross-Functional Teams to Enhancing Quality of Decision-Making During the Development and Review of Medicines

Session Chair(s)

Magda  Bujar, PhD, MSc

Magda Bujar, PhD, MSc

Senior Manager, Regulatory Programme and Strategic Partnerships

Centre for Innovation in Regulatory Science (CIRS), United Kingdom

This session illustrates how implementation of decision science and quality decision-making practices can improve transparency and accountability, minimise bias and ultimately enable better processes for cross-functional company and agency teams.

Learning Objective : Discuss how to increase the awareness of decision science including types of biases and potential solutions for teams; Describe tools for assessing the quality of decision-making practices, ensuring their implementation and documentation; Illustrate experiences from a company and an agency on the practical application of such approaches to enhance decision transparency and accountability across teams.

Speaker(s)

Marilena  Bassi, MA

Regulatory Agency Viewpoint: Update on HPFB Regulatory Decision Guide

Marilena Bassi, MA

Health Canada, Canada

Senior Executive Director, Therapeutic Products Directorate

Jeremy  Jokinen, PhD, MS

Decision Quality in the Pharmaceutical Industry: Successes and Opportunities - The Industry Point of View

Jeremy Jokinen, PhD, MS

Bristol-Myers Squibb Company, United States

Vice President and Head, Safety Evidence and Sciences

Carl  Spetzler, PhD

Decision Professional Viewpoint

Carl Spetzler, PhD

Strategic Decisions Group, United States

Chief Executive Officer

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.